MetLife, Inc.· MET

The Case for Holding MetLife Stock: What Investors Need to Know

MET's diversified portfolio, strong cash generation and global growth support premium gains, while investment income volatility remains a key risk.

MetLife CEO and CFO to Speak at the 2026 KBW Insurance Conference

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, will participate in a fireside chat at the 2026 Keefe, Bruyette & Woods Annual Insurance Conference on Wednesday, Sept. 9, 2026, from 9:15 am to 9:55 am ET. The live webcast can be listened to by clicking here. Please visit the link at least 15 minut.

Emerald Investment Advisers LLC Invests $3.46 Million in MetLife, Inc. $MET

Emerald Investment Advisers LLC acquired a new position in MetLife, Inc. (NYSE: MET) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 40,917 shares of the financial services provider's stock, valued at approximately $3,462,000. Other institutional investors and hedge

EP Wealth Advisors LLC Purchases New Holdings in MetLife, Inc. $MET

EP Wealth Advisors LLC acquired a new position in shares of MetLife, Inc. (NYSE: MET) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 21,942 shares of the financial services provider's stock, valued at approximately $1,857,000. A

$27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren't Over

Several industry giants that have seen impressive share price performance in 2026 recently made big-time buyback announcements. Share repurchases can do more than reduce share counts—they can also signal that management sees enough cash-flow strength and balance-sheet flexibility to keep returning capital after a strong run.

MetLife price target raised to $111 from $103 at Morgan Stanley

MetLife price target raised to $103 from $97 at Jefferies

MetLife price target raised to $105 from $102 at UBS

MetLife price target raised to $94 from $93 at Barclays

MetLife price target raised to $93 from $89 at Morgan Stanley